Atrial fibrillation in haemodialysis patients without a vitamin K antagonist: Insight from the RAKUEN study

Back

ESC Premium Access

Atrial fibrillation in haemodialysis patients without a vitamin K antagonist: Insight from the RAKUEN study

Session: Antithrombotic therapy in atrial fibrillation 1

Topic: Atrial fibrillation (AF)

Speaker: Doctor W. Mitsuma (Niigata, JP)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Wataru Mitsuma

Shinrakuen Hospital, Niigata (Japan)

0 follower

5 more presentations in this session

Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care

Speaker: Doctor K. Bouillon (Saint Denis, FR)

Access

Abstract

Slides

Alcohol abuse is associated with increased risk of ischemic stroke in low risk patients with non-valvular atrial fibrillation.

Speaker: Doctor F. Al-Khalili (Stockholm, SE)

Access

Abstract

Slides

Do baseline characteristics account for geographical variations in event rates in patients with newly diagnosed atrial fibrillation? The GARFIELD-AF registry

Speaker: Professor K. Fox (Edinburgh, GB)

Access

Abstract

Slides

Death, stroke and major bleeding risk in patients older than 85 years with atrial fibrillation

Speaker: Doctor Y. Arnson (Kfar Saba, IL)

Access

Abstract

Slides

Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015

Speaker: Mr K. Gadsboell (Hellerup, DK)

Access

Abstract

Slides

Access the full session

Antithrombotic therapy in atrial fibrillation 1

Speakers: Doctor W. Mitsuma, Doctor K. Bouillon, Doctor F. Al-Khalili, Professor K. Fox, Doctor Y. Arnson...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources